EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Silk Road Medical's enterprise value is $578.7 Mil.
Silk Road Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-45.1 Mil. Therefore, Silk Road Medical's EV-to-EBITDA for today is -12.84.
The historical rank and industry rank for Silk Road Medical's EV-to-EBITDA or its related term are showing as below:
SILK'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -70.95 Med: -28.71 Max: -3.26
Current: -12.87
During the past 7 years, the highest EV-to-EBITDA of Silk Road Medical was -3.26. The lowest was -70.95. And the median was -28.71.
SILK's EV-to-EBITDA is ranked worse than 100% of 489
companies
in the Medical Devices & Instruments industry
Industry Median: 14.89
vs SILK: -12.87
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-23), Silk Road Medical's stock price is $17.73.
Silk Road Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.450. Therefore, Silk Road Medical's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Silk Road Medical EV-to-EBITDA Historical Data
The historical data trend for Silk Road Medical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Silk Road Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Silk Road Medical EV-to-EBITDA Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Silk Road Medical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Silk Road Medical's EV-to-EBITDA falls into.
Silk Road Medical EV-to-EBITDA Calculation
Silk Road Medical's EV-to-EBITDA for today is calculated as:
Silk Road Medical's current Enterprise Value is $578.7 Mil.
Silk Road Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-45.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Silk Road Medical (NAS:SILK) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Silk Road Medical's PE Ratio for today is calculated as:
Silk Road Medical's share price for today is $17.73.
Silk Road Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.450.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Silk Road Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Silk Road Medical (Silk Road Medical) Business Description
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy while maintaining a reduction in long-term stroke risk.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SILK has been successfully added to your 